Article Details
Retrieved on: 2022-11-19 14:45:22
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Jefferies Financial Group began coverage on shares of CTI BioPharma in a report on Thursday, September 1st. They issued a “buy” rating and a $13.00 ...
Article found on: www.etfdailynews.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here